Navigation Links
ConvaTec Announces 2014 Second Quarter Earnings Call

LUXEMBOURG, Aug. 14, 2014 /PRNewswire/ -- ConvaTec today announced that it will hold an analyst and investor call to discuss 2014 second quarter results on Tuesday, August 19, 2014. Ken Berger, CEO, and Nigel Clerkin, CFO, will host the call at 9:00 AM ET live via telephone.

To participate in the conference call within the U.S. and Canada, dial (877) 366-0267.

To participate in the conference call outside the U.S. and Canada, dial (760) 666-3086.

The conference ID is 88736401.

Participants should dial in 10 minutes prior to the start of the call. The Company's 2014 Second Quarter Report will be available on the Company's website prior to the call under the Investors tab at

For more information, please contact

About ConvaTec
ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners. More information is available at


Investor Relations:
Robert McKee
Senior Vice President

Media Relations:
Punnie Donohue

Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Announces 2013 Journal Impact Factor Highlights
2. Cardium Announces Review in Journal Of Cardiovascular Pharmacology Finds Gene Therapy For Subset Of Heart Disease Patients Highly Warranted
3. NORD Announces Agenda for 2014 Rare Diseases and Orphan Products Breakthrough Summit
4. Whitehouse Laboratories Announces Participation at 13th Annual Contract Pharma Conference
5. FutureCeuticals Announces Publication of Human Clinical Study on ability of a dietary supplement ingredient to inhibit free radical production in vivo
6. BioNano Genomics Announces The Purchase Of The Irys System By The Wellcome Trust Sanger Institute
7. FlexTech Alliance Announces 2015FLEX Conference Theme, Call for Papers and Advisory Committee
8. Fertility Associates of Memphis Announces New Physician
9. Regado Biosciences Announces Second Quarter 2014 Financial Results and Corporate Highlights
10. OXIS International announces plans to Enter the Cannabis Biotech Sector, Completion of Financing, Changes to the Board of Directors
11. Braskem announces 2Q14 Results
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. ... will provide a corporate overview. th Annual Oppenheimer ... p.m. ET/10:00 a.m. PT . Jim Mazzola , vice ... overview. --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider ... , today announced that the company has set a new ... 391% quarter on quarter growth posted for Q3 of 2014 to ... and Mexico , with the establishment of an ... 2015. --> United Kingdom and ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)... 2015  A golden retriever that stayed healthy despite ... has provided a new lead for treating this muscle-wasting ... Institute of MIT and Harvard and the University of ... Cell, pinpoints a protective gene that ... effects. The Boston Children,s lab of Lou Kunkel ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):